Cargando…

Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications

Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerchen, Martin Fungisai, Kirsch, Peter, Feld, Gordon Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596945/
https://www.ncbi.nlm.nih.gov/pubmed/34529303
http://dx.doi.org/10.1002/hbm.25664
_version_ 1784600502516842496
author Gerchen, Martin Fungisai
Kirsch, Peter
Feld, Gordon Benedikt
author_facet Gerchen, Martin Fungisai
Kirsch, Peter
Feld, Gordon Benedikt
author_sort Gerchen, Martin Fungisai
collection PubMed
description Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with very large data sets virtually every voxel might become significant. It is thus desirable to complement significance testing with procedures like inferiority and equivalence tests that allow to formally compare effect sizes within and between data sets and offer novel approaches to obtain insight into fMRI data. The major component of these tests are estimates of standardized effect sizes and their confidence intervals. Here, we show how Hedges' g, the bias corrected version of Cohen's d, and its confidence interval can be obtained from SPM t maps. We then demonstrate how these values can be used to evaluate whether nonsignificant effects are really statistically smaller than significant effects to obtain “regions of undecidability” within a data set, and to test for the replicability and lateralization of effects. This method allows the analysis of fMRI data beyond point estimates enabling researchers to take measurement uncertainty into account when interpreting their findings.
format Online
Article
Text
id pubmed-8596945
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85969452021-12-02 Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications Gerchen, Martin Fungisai Kirsch, Peter Feld, Gordon Benedikt Hum Brain Mapp Technical Report Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with very large data sets virtually every voxel might become significant. It is thus desirable to complement significance testing with procedures like inferiority and equivalence tests that allow to formally compare effect sizes within and between data sets and offer novel approaches to obtain insight into fMRI data. The major component of these tests are estimates of standardized effect sizes and their confidence intervals. Here, we show how Hedges' g, the bias corrected version of Cohen's d, and its confidence interval can be obtained from SPM t maps. We then demonstrate how these values can be used to evaluate whether nonsignificant effects are really statistically smaller than significant effects to obtain “regions of undecidability” within a data set, and to test for the replicability and lateralization of effects. This method allows the analysis of fMRI data beyond point estimates enabling researchers to take measurement uncertainty into account when interpreting their findings. John Wiley & Sons, Inc. 2021-09-16 /pmc/articles/PMC8596945/ /pubmed/34529303 http://dx.doi.org/10.1002/hbm.25664 Text en © 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Report
Gerchen, Martin Fungisai
Kirsch, Peter
Feld, Gordon Benedikt
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title_full Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title_fullStr Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title_full_unstemmed Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title_short Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
title_sort brain‐wide inferiority and equivalence tests in fmri group analyses: selected applications
topic Technical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596945/
https://www.ncbi.nlm.nih.gov/pubmed/34529303
http://dx.doi.org/10.1002/hbm.25664
work_keys_str_mv AT gerchenmartinfungisai brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications
AT kirschpeter brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications
AT feldgordonbenedikt brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications